EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain.

Irene Delgado Sillero, Nerea Lopetegui Lia,Luis Felipe Sánchez Cousido,Mariam Rojas Piedra,Blanca Távara Silva,Maria Luisa Garrido Onecha, Soledad Medina Valdivieso, Nieves Alonso Horcajo, Cristina Díez Tascón,Ana López González, Carmen Castañón López, Manuela Pedraza Lorenzo,Andrés García Palomo,Vicente Martín,Pilar Diz Tain

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners（2022）

引用 1|浏览1

暂无评分

摘要

Real-world analysis of this data confirms that treatment with TKI is beneficial for patients diagnosed with EGFR-mutated NSCLC. Our OS outcomes were similar to those reported in clinical trials.

查看译文

关键词

19 deletion,EGFR mutation,NSCLC,TKI

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要